Chronic Kidney Disease-associated Pruritus

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
NCT05524467 | PHASE 3 | OBSERVATIONAL

Vifor International Inc. is seeking real-world evidence (RWE) to better understand the epidemiology, patient characteristics, and management of CKD-aP in the real-world clinical setting.

Trial Information
94 Sites
3100 Participants
Recruiting
18 Years to 70 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

SUBMIT
Aschaffenburg,Germany
Balingen,Germany
Braunschweig,Germany
Einbeck,Germany
Eisenach,Germany
Flensburg,Germany
Freiburg,Germany
Freiburg,Germany
Hanover,Germany
Herne,Germany
Kiel,Germany
Leipzig,Germany
Mainz,Germany
Saalfeld/Saale,Germany
Sömmerda,Germany
Witten,Germany
Wuppertal,Germany
Acquaviva Delle Fonti,Italy
Bari,Italy
Civitavecchia,Italy
Firenze,Italy
L'Aquila,Italy
Lecce,Italy
Macerata,Italy
Mestre,Italy
Milano,Italy
Milano,Italy
Milano,Italy
Modena,Italy
Monza,Italy
Palermo,Italy
Parma,Italy
Pavia,Italy
Pisa,Italy
Pistoia,Italy
Reggio Calabria,Italy
Roma,Italy
Rome,Italy
Treviso,Italy
Trieste,Italy
Verona,Italy
Viterbo,Italy
Cascais,Portugal
Faro,Portugal
Gandra,Portugal
Gondomar,Portugal
Leiria,Portugal
Porto,Portugal
Sacavém,Portugal
Palma De Mallorca,Mallorca,Spain
Almería,Spain
Barcelona,Spain
Barcelona,Spain
Barcelona,Spain
Barcelona,Spain
Benidorm,Spain
Cadiz,Spain
Gijón,Spain
Granada,Spain
Jaen,Spain
Las Palmas,Spain
León,Spain
Madrid,Spain
Madrid,Spain
Madrid,Spain
Madrid,Spain
Pamplona,Spain
Santander,Spain
Sevilla,Spain
Sevilla,Spain
Terrassa,Spain
Valencia,Spain
Valencia,Spain
Valencia,Spain
Linköping,Sweden
Malmö,Sweden
Norrköping,Sweden
Stockholm,Sweden
Trollhättan,Sweden
Umeå,Sweden
Uppsala,Sweden
Örebro,Sweden
Baden,Switzerland
Bern,Switzerland
Frauenfeld,Switzerland
Lugano,Switzerland
Zurich,Switzerland
Bradford,United Kingdom
Hull,United Kingdom
Leicester,United Kingdom
London,United Kingdom
London,United Kingdom
Nottingham,United Kingdom
Sheffield,United Kingdom

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov